Achieve Life Sciences Inc Stock Nasdaq
Equities
US68230A1060
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 257K | Capitalization | 156M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -37M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 605 x |
P/E ratio 2024 * |
-4.28
x | P/E ratio 2025 * |
-4.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.72% |
Latest transcript on Achieve Life Sciences Inc
Managers | Title | Age | Since |
---|---|---|---|
John Bencich
CEO | Chief Executive Officer | 47 | 14-07-31 |
Richard Stewart
CHM | Chairman | 65 | 15-04-30 |
Cindy Jacobs
PSD | President | 66 | 08-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 22-03-13 |
Thomas King
BRD | Director/Board Member | 69 | 23-03-28 |
Cindy Jacobs
PSD | President | 66 | 08-07-31 |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |